Adrenergic beta1-Antagonists [MoA]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Adrenergic beta1-Antagonists [MoA] includes 2 drugs with a combined 13,741 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
13,741
Combined Reports
All Adrenergic beta1-Antagonists [MoA] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| CARVEDILOL | Carvedilol Phosphate | 13,678 | 2,246 | 6,005 | 16.4% |
| LANDIOLOL | RAPIBLYK | 63 | 14 | 39 | 22.2% |
Common Side Effects in Adrenergic beta1-Antagonists [MoA] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Hypotension | 1,822 | 109 |
| Dyspnoea | 1,143 | 35 |
| Dizziness | 1,138 | 23 |
| Drug ineffective | 1,127 | 59 |
| Fatigue | 1,020 | 26 |
| Completed suicide | 1,019 | 1,019 |
| Bradycardia | 871 | 74 |
| Toxicity to various agents | 690 | 384 |
| Cardiac failure | 636 | 82 |
| Asthenia | 562 | 22 |